These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32051830)

  • 41. [Postoperative cholangitis of balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma].
    Okabe K; Beppu T; Komori H; Sano O; Yamanaka T; Haraoka K; Ouchida Y; Fujiyama S; Baba H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2119-21. PubMed ID: 25731442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue.
    Matsuo N; Uchida H; Nishimine K; Soda S; Oshima M; Nakano H; Nagano N; Nishimura Y; Yoshioka T; Guo Q
    J Vasc Interv Radiol; 1993; 4(4):543-9. PubMed ID: 8394758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
    Kang JW; Kim JH; Ko GY; Gwon DI; Yoon HK; Sung KB
    Acta Radiol; 2012 Jun; 53(5):545-50. PubMed ID: 22547388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Supplemental conventional transarterial embolization/chemoembolization therapy via extrahepatic arteries for hepatocellular carcinoma.
    Huang Y; Jia Z; Tu J; Shen T; Tian F; Jiang G
    J Cancer Res Ther; 2017; 13(4):720-724. PubMed ID: 28901321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short-term results.
    Ogawa M; Takayasu K; Hirayama M; Miura T; Shiozawa K; Abe M; Matsumoto N; Nakagawara H; Ohshiro S; Yamamoto T; Tanaka N; Moriyama M; Mutou H; Yamamoto Y; Irie T
    Hepatol Res; 2016 Mar; 46(3):E60-9. PubMed ID: 25974615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience.
    Minami Y; Minami T; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Tsurusaki M; Yagyu Y; Ueshima K; Nishida N; Murakami T; Kudo M
    Oncology; 2015; 89 Suppl 2():27-32. PubMed ID: 26584033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus.
    Zhu LZ; Xu S; Qian HL
    World J Gastroenterol; 2018 Jun; 24(23):2501-2507. PubMed ID: 29930471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation.
    Zhang W; Xu AH; Wang W; Wu YH; Sun QL; Shu C
    BMC Cancer; 2019 Nov; 19(1):1041. PubMed ID: 31690274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Change in Imaging Findings on Angiography-Assisted CT During Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
    Yoshimatsu R; Yamagami T; Ishikawa M; Kajiwara K; Aikata H; Chayama K; Awai K
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):865-74. PubMed ID: 26711803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary study.
    Yasui D; Murata S; Ueda T; Sugihara F; Onozawa S; Kawamoto C; Kumita S
    Acta Radiol; 2018 Mar; 59(3):266-274. PubMed ID: 28651444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
    Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
    World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome.
    Matsui O; Miyayama S; Sanada J; Kobayashi S; Khoda W; Minami T; Kozaka K; Gabata T
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):407-9. PubMed ID: 19885639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous Thermal Segmentectomy: Proof of Concept.
    Lucatelli P; Argirò R; Crocetti L; Rocco B; Bozzi E; Gasparrini F; Tanzilli A; Catalano C; Iezzi R
    Cardiovasc Intervent Radiol; 2022 May; 45(5):665-676. PubMed ID: 35355092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transarterial chemoembolization for hepatocellular carcinoma: significance of extrahepatic collateral supply.
    Paul SB; Gamanagatti SR; Mukund A; Abbas SZ; Acharya SK
    Indian J Cancer; 2011; 48(3):339-44. PubMed ID: 21921335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
    Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
    World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of CT vascularization patterns for survival prognosis in patients with hepatocellular carcinoma treated by conventional TACE.
    Hasdemir DB; Dávila LA; Schweitzer N; Meyer BC; Koch A; Vogel A; Wacker F; Rodt T
    Diagn Interv Radiol; 2017; 23(3):217-222. PubMed ID: 28256449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
    Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
    J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.